Dr. Vicki Goodman, VP, Therapeutic Area Head, Late Stage Oncology at Merck discusses the recent Phase 3 KEYNOTE-204 positive EU CHMP opinion for expanded approval of KEYTRUDA® (pembrolizumab) for the treatment of relapsed or refractory classical Hodgkin lymphoma (cHL) that meet certain criteria.
Geneticist, Dr. Jennifer Ibrahim, MD, Head of North America Medical Affairs, Rare Disease at Sanofi Genzyme discusses rare genetic disease, why it’s so hard to diagnose, and the important role of genetic counselors for families who had a history of a rare genetic disease or learn of it. She talks about some new technologies and tests that are helping diagnose rare genetic diseases and what she anticipates will improve diagnosis and treatment moving forward.
Dr. Nick Medendorp, CEO of UV Innovators discusses NuvaWave, the world’s first UV handheld to demonstrate killing more than 99.9% of the live COVID virus in just one second. He talks about the challenges of disinfection today, the value of UV light disinfection in fighting dangerous pathogens, and his mission to help businesses during these challenging times.
Ed Tracy, an award-winning broadcast veteran, writer, and editor discusses his new book “Gorilla In The Room And Other Stories” (Feb 2021) which started coming together while battling stage 3 colon cancer.
Returned guest, Bruce Boise, author of the book “Cold Comfort: One Man’s Struggle to Stop the Illegal Marketing of Powerful Opioid Drugs and Save Lives” discusses the recent 8.3 billion dollar Purdue Pharma Opioid settlement.
Allison London Brown, CEO of UVision360, Inc. in North Carolina, discusses the Luminelle DTx Hysteroscopy System. Traditionally, these procedures are conducted in a hospital or ambulatory setting. But the Luminelle system is compact and designed to be used in the doctor’s office, and the company is expected to file an application with the FDA that will allow doctors to conduct the first visual hysteroscope biopsy outside a hospital setting. This technology will help to fill an unmet medical need brought on by the COVID pandemic.
Dr. Mark Allen, MD, co-founder and CEO of Elevian, developer of therapies to treat age-related diseases like stroke and diabetes, discusses the drug candidate, recombinant growth differentiation factor 11 (rGDF11) with broad therapeutic benefits demonstrated in numerous animal studies. “Science” recognized GDF11 as a top scientific breakthrough calling it “the rejuvenation factor”.
Returned guest, Dr. Maria Milla, MD, Section Chief, Nicklaus Children’s Pediatric Care Centers discusses the talk of the increase in childhood obesity due to increased anxiety and physical inactivity in children during the pandemic. Obesity leads to many chronic problems later in life including type 2 diabetes and hypertension and she talks about how providers can discuss the health impacts with parents.
Dr. Melanie Dean, Ph.D., psychologist, discusses her new book ” The Hidden Power of Emotions: How to Activate Your Energy Field and Transform Your Life”, a culmination of 10 years of research in psychology, molecular physics, and quantum physics. She has discovered that there is a science-backed system for tapping your intuition’s power and using it to get what you want.
Dr. Leigh Peterson, Ph.D., Vice President of Product Development at United Therapeutics discusses data published in the “New England Journal of Medicine” (Jan 2021) on the INCREASE study evaluating Tyvaso in pulmonary hypertension associated with interstitial lung disease (PH-ILD). The INCREASE study is the first to demonstrate a clear benefit in patients with PH-ILD, a life-threatening disease with no currently FDA-approved treatments. She talks about what’s next for Tyvaso as they look to achieve FDA approval.